Clinical trial
Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
NCT00628199 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- September 30, 2007
- Completion date
- January 31, 2030
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.